Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study

Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been recognized as potent antioxidant agents. Since SGLT2i are nephroprotective drugs, we aimed to examine the urine antioxidant status in patients with type 2 diabetes mellitus (T2DM). One hundred and one subjects participated in this study, i...

Full description

Bibliographic Details
Main Authors: Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Katarzyna Sedlaczek, Patryk Główczyński, Hanna Kwiendacz, Tomasz Sawczyn, Weronika Hajzler, Karolina Drożdż, Mirela Hendel, Krzysztof Irlik, Paweł Stelmach, Piotr Adamczyk, Andrzej Paradysz, Sławomir Kasperczyk, Tomasz Stompór, Janusz Gumprecht
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Oxidative Medicine and Cellular Longevity
Online Access:http://dx.doi.org/10.1155/2021/5593589

Internet

http://dx.doi.org/10.1155/2021/5593589

Similar Items